Your Immune Health Holds The Key to Better Care.

Access Your Immune Health Insights Here.

OncoHelix provides comprehensive immune health analysis through serum-based & cell-based immunology panels. These tests reveal insights about your natural immune function and specific immunologic responses to diseases and treatments, helping predict health outcomes.

Discover the Power of Personalized Immune Insights

Our Immunology Panels

Support Cancer Monitoring

Aid in Immune Disorder Testing

Assess Immune Function

Serum-Based Panels

OncoHelix provides the ability to determine a person’s cytokine profile to investigate and risk-stratify those individuals undergoing cytokine storm/cytokine release syndrome. Traditional single cytokine tests and cytogenetic assessments are limited and non-specific in predicting those patients at high risk for cytokine storm or cytokine release syndrome.

Explore Our Panels

  • Reports on 34 analytes in serum with reference ranges

    Eotaxin/CCL11, GM-CSF, GRO alpha/CXCL1, IFN alpha, IFN gamma, IL-1 beta, IL-1 alpha, IL-1RA, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8/CXCL8, IL-9, IL-10, IL-12 p70, IL-13, IL-15, IL-17A, IL-18, IL-21, IL-22, IL-23, IL-27, IL-31, IP-10/CXCL10, MCP-1/CCL2, MIP-1 alpha/CCL3, MIP-1 beta/CCL4, RANTES/CCL5, SDF1 alpha/CXCL12, TNF alpha, TNF beta/LTA.)

  • Reports on 2 analytes in serum with reference ranges

    sIL2Ra and sCD163

  • Includes 34-Plex Cytokine/Chemokine Panel + 2-Plex Soluble Receptor Panel

    Eotaxin/CCL11, GM-CSF, GRO alpha/CXCL1, IFN alpha, IFN gamma, IL-1 beta, IL-1 alpha, IL-1RA, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8/CXCL8, IL-9, IL-10, IL-12 p70, IL-13, IL-15, IL-17A, IL-18, IL-21, IL-22, IL-23, IL-27, IL-31, IP-10/CXCL10, MCP-1/CCL2, MIP-1 alpha/CCL3, MIP-1 beta/CCL4, RANTES/CCL5, SDF1 alpha/CXCL12, TNF alpha, TNF beta/LTA.)

    sIL2Ra and sCD163

Why Test with OncoHelix?

Using a Luminex-based serum immunologic test conducted at OncoHelix's clinical diagnostic facilities, three specialized panels—Enhanced 36-Plex, 34-plex, and 2-plex cytokine and soluble receptor profiling panels—are utilized to identify

01

Specific cytokine profile compared to a baseline of normal healthy people.

02

Investigation of an Inflammatory Disease.

03

Diagnosis of acute inflammatory conditions like HLH.

04

Investigation and monitoring of cytokine storms.

05

Changes in an individual’s cytokine profile - monitoring disease progression and/or therapy response.

Available Turnaround Time Options

Regular

2 Weeks

STAT

48 Hours

Clinical Utilizations

Investigate and Monitor Cytokine Profile for At-Risk Patients

01

02

03

Autoimmune conditions like arthritis

Acute inflammatory conditions like HLH

Car-T Cell Therapy Patients

Monitor for Response to Anti-Cytokine Syndrome Therapies

01

02

Anti-cytokine (e.g., anti-IL-1, anti-IL-6 or anti-TNFa therapy)

Other therapies with continued serum testing after treatment have been initiated

Recommendations for Ordering Panels Based on Turnaround Time

*Hemophagocytic Lymphohistocytosis (HLH), Macrophage Activation Syndrome (MAS), Kawasaki Syndrome, Sepsis/Toxic Shock Meningitis, Pneumonia & more.

**Arthritis, Auto-Inflammatory diseases, Autoimmune diseases, Immunodeficiency, Chronic Inflammation

Cell-Based Panels

OncoHelix’s cellular-based immunology panels provide a detailed assessment of immune cell populations and their functional activity. These panels offer critical insights into immune dysregulation, guide personalized therapeutic strategies, and support the management of conditions such as immune disorders, inflammatory diseases, and fertility challenges.

Explore Our Panels

  • Relative and absolute counts of 8 different lymphocytes

    Total T cells (CD3), Helper T cells (CD3+CD4+), Cytotoxic T cells (CD3+CD8+), Double negative T cells (CD3+CD4-CD8-), Double positive T cells (CD3+CD4+CD8+), ratio of CD4:CD8, natural killer cells (NK)(CD3-CD16/56+), NK-T cells(CD3+CD16/56+), and B-cells(CD19)

  • NK cell function by resulting percentage

    (Stimulated CD107a% - unstimulated CD107a%) of CD107a+ NK cells

  • Ratio of Th1(TNFa and IFNy): IL10 by T helper Cells

Ordering a Test

  • Patient details are filled out at the top of the requisition under “Patient Information.”
  • Physician details are completed under “Order Information.”
  • Physician specifies the patient’s condition under “Indication.”
  • Physician selects the type of panel test required under “Test Request”.

Step 1 Physician To Complete the OncoHelix Immunology Requisition.

Step 2 Send the completed requisition to the OncoHelix lab by Fax to 403 210 8176.

Note: OncoHelix Immunology testing is available at all locationsa across Canada, the US, and worldwide. Samples can be shipped to the OncoHelix lab for testing from anywhere, there is no geographic limitation to conduct a blood or serum-basesd test.

Step 3 OncoHelix will contact you in 3 business days.

An OncoHelix customer navigator will contact you within 3 business days to arrange for the test to be completed. For your safety, our OncoHelix customer navigator will be able to identify themselves to you by providing your doctor's information and details written on the OncoHelix form that you sent.

Please have your credit card information ready when our OncoHelix customer navigator contacts you, as we only accept credit card payments. A secure payment link will be provided for your convenience.

Step 4 Test Report will be sent to both your physician and you.

Please see below the Turnaround Time for your test: starting from the arrival time of the prepared specimen to the OncoHelix Lab in Calgary, Alberta to the final result reviewed by our team of pathologists. Your ordering physician will receive an electronic report once your test has been completed and your profile has been analyzed. The patient will also receive a copy of the report.

Requisition Form